Clinical Trial Update: Efficacy and Safety of Different Concentrations of ZK245186 in Atopic Dermatitis (AD) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing efficacy and safety of different concentrations of ZK245186 in Atopic Dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• ZK245186

Snippet

Sponsor: Bayer | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED